Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 39kWORD 9k
31 October 2019
Question for written answer
to the Commission
Rule 138
Pascal Arimont
 Answer in writing 
 Subject: Pooling forces in negotiations on the price of medicines

In late October 2019, nine countries — Belgium, the Netherlands, Luxembourg, Ireland, Portugal, Sweden, Denmark, Switzerland and Norway — launched a joint project entitled International Horizon Scanning Initiative (IHSI). One aim the countries have in developing this project is to work together to prepare for the arrival on the market of new medicines and medical-technological innovations and, for example, to negotiate cheaper prices for innovative and often expensive medicines.

Does the Commission support this cooperation between countries with the aim of securing cheaper prices for medicines?

Does the Commission intend to encourage a similar pooling of forces involving all the Member States so that as many EU citizens as possible can benefit from the cheaper prices for medicines which this approach could secure by drawing on growing market power in negotiations with manufacturers?

Last updated: 25 November 2019Legal notice - Privacy policy